Filters

GALNT13/GalNAc-T13 Antibody, FITC Conjugated

GALNT13/GalNAc-T13 Antibody, FITC Conjugated size: 0.1ml 333

Price 333
Size 0.1ml
Long name FITC Conjugated, GALNT13/GalNAc-T13 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationAnti-FITC Antibody
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenGALNT13/GalNAc-T13
SpecificityThis is a highly specific antibody against GALNT13/GalNAc-T13
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from human GALNT13/GalNAc-T13
Gene ID number114805
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background GalNAc-T13 (Polypeptide N-acetylgalactosaminyltransferase 13), GalNAc-T13 may be responsible for the synthesis of Tn antigen in neuronal cells, The N-terminal domain is involved in substrate binding and manganese coordination, With specific expression in the central nervous system, also known as UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13, is a 556 amino acid protein that displays much stronger enzymatic activity than GalNAc-1 towards GalNAc transfer to mucin peptides such as Muc5a and Muc7, thereby initiating mucin-type O-linked glycosylation in the Golgi apparatus, which is a universal carcinoma marker on malignant cells, while the C-terminal domain is involved in UDP-Gal binding and catalytic reaction, The UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes are substrate-specific proteins that catalyze the transfer of GalNAc (N-acetylgalactosamine) to serine and threonine residues onto various proteins
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission494nm/518nm
Synonyms KIAA1918 GalNAc-T13
Properties Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetGALNT13/GalNAc-T13 Conjugated
Short name FITC Conjugated, GALNT13/GalNAc-T13 Antibody
Technique Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelFITC
Alternative name fluorecein coupled, GALNT13/GalNAc-T13 (Antibody to)
Alternative techniqueantibodies
Identity 23242
Gene GALNT13
Long gene name polypeptide N-acetylgalactosaminyltransferase 13
Synonyms gene name UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)
Synonyms name UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 polypeptide GalNAc transferase 13
Locus 2q23, 1 , 3-q24
Discovery year 2003-12-02
GenBank acession AB067505
Entrez gene record 114805
Pubmed identfication 11572484 12407114
RefSeq identity NM_052917
Classification Polypeptide N-acetylgalactosaminyltransferases
Havana BLAST/BLAT OTTHUMG00000131917

Subscribe to our Newsletter